Kanamata Reddy

934 total citations
27 papers, 706 citations indexed

About

Kanamata Reddy is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Kanamata Reddy has authored 27 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Kanamata Reddy's work include Melanoma and MAPK Pathways (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Computational Drug Discovery Methods (4 papers). Kanamata Reddy is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Computational Drug Discovery Methods (4 papers). Kanamata Reddy collaborates with scholars based in United States, China and South Korea. Kanamata Reddy's co-authors include Zigang Dong, Ann M. Bode, Mee‐Hyun Lee, Sungyoung Lee, Myoung Ok Kim, Dong Joon Kim, Hanyong Chen, Kangdong Liu, Jong‐Eun Kim and Feng Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Kanamata Reddy

26 papers receiving 696 citations

Peers

Kanamata Reddy
Jungsug Gwak South Korea
Nehal Gupta United States
Hong-Gyum Kim United States
Chan‐Hun Jung South Korea
Ae Jin Jeong South Korea
Pui–Kei Wu United States
Chuan‐Chou Tu Taiwan
Diana Vara‐Ciruelos Spain
Tomomi Masuda Japan
Anusha Bishayee United States
Jungsug Gwak South Korea
Kanamata Reddy
Citations per year, relative to Kanamata Reddy Kanamata Reddy (= 1×) peers Jungsug Gwak

Countries citing papers authored by Kanamata Reddy

Since Specialization
Citations

This map shows the geographic impact of Kanamata Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanamata Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanamata Reddy more than expected).

Fields of papers citing papers by Kanamata Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanamata Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanamata Reddy. The network helps show where Kanamata Reddy may publish in the future.

Co-authorship network of co-authors of Kanamata Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Kanamata Reddy. A scholar is included among the top collaborators of Kanamata Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanamata Reddy. Kanamata Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Deborah, Raja Dey, Brian C. Richardson, et al.. (2023). Human uridine 5′-monophosphate synthase stores metabolic potential in inactive biomolecular condensates. Journal of Biological Chemistry. 299(3). 102949–102949.
2.
Jin, Guoguo, Kangdong Liu, Ke Yao, et al.. (2020). Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer. Oncogene. 39(43). 6733–6746. 16 indexed citations
3.
Roh, Eunmiri, Kanamata Reddy, Tatyana A. Zykova, et al.. (2020). Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032. Oncogene. 39(21). 4170–4182. 14 indexed citations
4.
Zhang, Tianshun, Qiushi Wang, Moeez Rathore, et al.. (2020). HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E. Theranostics. 10(21). 9721–9740. 20 indexed citations
5.
Zhang, Tianshun, Qiushi Wang, Ge Gao, et al.. (2018). The Ashitaba ( Angelica keiskei ) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prevention Research. 11(10). 607–620. 11 indexed citations
6.
Shin, Seung Ho, Do Young Lim, Kanamata Reddy, et al.. (2018). Abstract 3839: A small-molecule inhibitor of the β-catenin-TCF4 interaction suppresses colorectal cancer growth in vitro and in vivo. Cancer Research. 78(13_Supplement). 3839–3839. 1 indexed citations
7.
Gao, Ge, Tianshun Zhang, Kanamata Reddy, et al.. (2017). ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK. Molecular Cancer Therapeutics. 16(9). 1843–1854. 27 indexed citations
8.
Shin, Seung Ho, Do Young Lim, Kanamata Reddy, et al.. (2017). A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo. EBioMedicine. 25. 22–31. 53 indexed citations
9.
Sheng, Yuqiao, Kangdong Liu, Qiong Wu, et al.. (2016). PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts. Oncotarget. 7(21). 30977–30989. 3 indexed citations
10.
Sheng, Yuqiao, Wěi Li, Feng Zhu, et al.. (2014). 3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer. Journal of Biological Chemistry. 289(41). 28192–28201. 19 indexed citations
11.
Byun, Sanguine, Sungyoung Lee, Ji‐Hoon Lee, et al.. (2013). USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer. Clinical Cancer Research. 19(14). 3894–3904. 110 indexed citations
12.
Jung, Sung Keun, Jong‐Eun Kim, Sungyoung Lee, et al.. (2013). The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer. Carcinogenesis. 35(1). 123–130. 30 indexed citations
13.
Kim, Dong Joon, Mee‐Hyun Lee, Kanamata Reddy, et al.. (2013). CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo. Carcinogenesis. 34(5). 1134–1143. 5 indexed citations
14.
Kim, Myoung Ok, Mee‐Hyun Lee, Naomi Oi, et al.. (2013). [6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis. 35(3). 683–691. 79 indexed citations
15.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2013). Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo. Molecular Cancer Therapeutics. 12(6). 950–958. 16 indexed citations
16.
Kim, Dong Joon, Yan Li, Kanamata Reddy, et al.. (2012). Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth. Cancer Research. 72(12). 3060–3068. 88 indexed citations
17.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2012). Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. Cancer Research. 73(2). 716–724. 26 indexed citations
18.
Kim, Dong Joon, Kanamata Reddy, Myoung Ok Kim, et al.. (2011). (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo. Cancer Prevention Research. 4(11). 1842–1851. 27 indexed citations
19.
Li, Shengqing, Ann M. Bode, Feng Zhu, et al.. (2011). TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling. Carcinogenesis. 32(5). 779–785. 49 indexed citations
20.
Yadava, R. N. & Kanamata Reddy. (2003). Novel bioactive flavonol glycoside from Desmodium gangeticum DC.. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jungsug Gwak Breakdown of academic impact, for papers by Nehal Gupta Breakdown of academic impact, for papers by Hong-Gyum Kim Breakdown of academic impact, for papers by Chan‐Hun Jung Breakdown of academic impact, for papers by Ae Jin Jeong Breakdown of academic impact, for papers by Pui–Kei Wu Breakdown of academic impact, for papers by Chuan‐Chou Tu Breakdown of academic impact, for papers by Diana Vara‐Ciruelos Breakdown of academic impact, for papers by Tomomi Masuda Breakdown of academic impact, for papers by Anusha Bishayee
Rankless by CCL
2026